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We investigated modulation of ~60”” expression in human mononuclear phagocytes. By analysis of [“Slmethionine-1abelled cells we found that 
synthesis of p60”” is higher in human monocytes compared to macrophages derived from in vitro cultivation of monocytes. Western blot analysis 
showed that expression of ~60”” in monocyte-derived macrophages can be enhanced if monocytes are differentiated into macrophages in the 
presence of interferon-y (IFN-y), or tumor necrosis factor-a (TNF-a). Enhanced ~60” expression caused by IFN-)I or TNF-a correlated with an 
enhanced autophosphorylating kinase activity assayed in anti-p60 ‘Ic immune precipitates. In vivo phosphorylation of ~60”” and analysis of 
phosphopeptides by tryptic digestion showed that treatment with cytokines did not affect the pattern of phosphorylation of distinct phosphopep- 
tides. The human monocytic cell lines, U937 and HL-60, induced to differentiate along the monocytic pathway by IFN-I, or a combination of 
IFN-y and TNF-a, expressed higher amounts of the pm=, but not of the ~59”” or p62p, kinase activity. These findings show that p60”” is 
modulated in the course of differentiation of human monocytes to macrophages, and that macrophage-activating cytokines increase p60src 
expression in human monocytederived macrophages. 
Macrophage; Cytokine; ~60”” 
1. INTRODUCTION 
Macrophages are cells distributed in all tissues [1,2], 
and derive from circulating monocytes which, once they 
have emigrated into the extravascular space, undergo a 
complex process of differentiation. Studies on mononu- 
clear phagocytes isolated from the peritoneal cavity of 
mice [3], or human alveoli [4-6], or on human mon- 
ocytes differentiated to macrophages by in vitro cultiva- 
tion [7-91 showed that differentiation to tissue macro- 
phages is accompanied by profound phenotypic 
changes. The functional state of mononuclear 
phagocytes can vary considerably depending on 
whether exposed to microbial-derived molecules or cy- 
tokines [l,lO]. 
In the last few years, a great deal has been learned 
about the role of a family of intracellular protein tyro- 
sine kinases, which show a high degree of homology 
with the product of the protooncogene c-src, in signal 
transduction. Members of the src family of tyrosine 
kinases are expressed in different tissues, including he- 
matopoietic cells (11-l 3). 
In studies on modulation of myristoylated proteins in 
human mononuclear phagocytes, we found that ~60”” 
kinase activity decreased uring differentiation of mon- 
ocytes to macrophages, but was up-modulated by the 
macrophage activating cytokines, IFN-)I and TNF-ol 
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[14]. The results presented in this paper show that the 
~60”” protein expression is modulated during differenti- 
ation of monocytes to macrophages, and as a conse- 
quence of cytokine treatment. We also show that differ- 
entiation of monocytic cell lines to cells with phenotypic 
and functional characteristics of mature monocytes, in- 
duced by IFN-y and TNF-a, is accompanied by induc- 
tion of p60”‘“. 
2. MATERIALS AND METHODS 
2.1. Cell isolation and cultivation 
Monocytes were isolated, differentiated to macrophages by in vitro 
cultivation, and treated with cytokines as previously described [14]. 
U937 and HL-60 cells were cultivated and induced to differentiate with 
cytokines as described in [ 151 and [ 161. Activation of monocyte-derived 
macrophages, and differentiation of myelomonocytic ell lines in- 
duced by IFN-y and TNF-cc was controlled by measurement of the 
capability to produce hydrogen peroxide in response to phorbol myris- 
tate acetate [9]. Populations of cytokine-treated monocyte-derived 
macrophages which, in response to phorbol myristate acetate, pro- 
duced amounts of hydrogen peroxide comparable to monocytes and 
5-10 times higher than control monocyte-derived macrophages were 
selected for the studies described in this paper. 
2.2. Methods 
Methods for labelling of cells, immune precipitation of proteins, and 
in vitro kinase assays were essentially as described in [17-191. 
2.3. Cell label&g with [3sS]methionine, or [“PJorthophosphate 
This was performed in methionine-free RPM1 1640 medium (Bio- 
chrom KG, Berlin, Germany), or phosphate-free DMEM medium 
(Biochrom KG) supplemented with 5% dialysed human (for mon- 
ocytes, or monocyte-derived macrophages) or foetal bovine (for my- 
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elomonocytic ell lines) serum. Cells were preincubated for 1 h in these 
media, then [“S]methionine (cell labelling grade, specific activity 10 
mCi/ml; Amersham, Amersham, UK) at a final concentration of 100 
@/ml, or [32P]orthophosphate (Amersham, specific activity 10 mCi/ 
ml) at a final concentration of 1 mCi/ml were added. After 4 h of 
incubation cells were washed twice with ice-cold TBS (20 mM Tris, 
pH 7.5, 150 mM NaCl) and lysed in 0.5 ml of 25 mM HEPES, pH 7.5, 
150 mM NaCl, 1% Nonidet P40 (NP40), 100 PM sodium orthovana- 
date, 1 mM EDTA, 10 mM NaF, 1 mM phenylmethylsulfonyl fluoride 
(PMSF), 10 PM leupeptin, 10 pM pepstatin, 1 mM dithiotreithol 
(DTT). For monocyte, or monocyte-derived macrophage monolayers, 
cells of one 10 cm* well of a 6-well plate [14] were lysed for each set 
of immune precipitations; U937 and HL-60 cells were lysed at a den- 
sity of 10 x lo6 cells/ml. Lysates were kept on ice for 10 min and then 
centrifuged at 12,000 x g for 10 min; supematants were used for im- 
mune precipitation experiments. 
2.4. Immune precipitation of lysates of [“S]methionine or [3ZP]ortho- 
phosphate-labelled cells 
Supematants of lysates of [35S]methionine- or [32P]orthophosphate- 
labelled cells were adjusted to the same concentration of labelled 
proteins on the basis of counts of trichloroacetic acid-precipitable 
cpm, and 0.5 ml rotated for 1 h at 4°C with 100~1 ofa 10% suspension 
of Staphylococcus aureus (Calbiochem, San Diego, CA). After centrif- 
ugation in a microfuge, supematants were divided into two aliquots 
and 2.5 pg purified antibodies were added. For immune precipitation 
of p60’“, the MAb 327 [20], kindly provided by Dr. S. Courtneidge, 
EMBL, Heidelberg, Germany, was used; in this case, control im- 
munoprecipitations were done with the anti-transferrin receptor, 
MAb 5E9 (American Type Culture Collection, ATCC, NIH, Be- 
thesda, MA). Lysates of U937 and HL-60 cells were immune precipi- 
tated also with control rabbit polyclonal Abs, or anti-p59”“, and 
anti-p62Y” antibodies, kindly provided by Dr. S. Courtneidge, or with 
the anti-Class I MHC antigens, MAb B9.12.1, kindly provided by Dr. 
R. Accolla, Istituto di Scienze Immunologiche, Verona, Italy. After 
2 h of incubation, lysates were centrifuged at 12,000 x g for 10 min, 
and the supematants transferred to tubes containing 5 ~1 of 10% 
Staphylococcus aureus; for collecting immune complexes with mouse 
MAb (327, 5E9, B9.12.1), this was pre-adsorbed with rabbit anti- 
mouse immunoglobulins (Sigma, St. Louis, MO). After 45 min of 
rotation at 4°C complexes were collected by centrifugation in a micro- 
fuge, and washed twice with RIPA buffer (25 mM Tris, pH 7.5, 150 
mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS, 1 mM 
DTT, 100 PM sodium orthovanadate) and once with Opper 1(25 mM 
Tris, pH 7.5, 1 M NaCl, 0.1% NP40), Opper 2 (25 mM Tris, pH 7.5, 
200 mM NaCl, 1 mM EDTA, 1% NP40,0.1% SDS), and Opper 3 (25 
mM Tris, pH 7.5, 0.1% NP40). The pellets were resuspended in 25 ~1 
of SDS-PAGE sample buffer, incubated at 95°C for 3 min, and the 
supernatants were subjected to a 10% SDS-polyacrylamide gel. 
[35S]Methionine-labelled proteins were analysed by fluorography ac- 
cording to Laskey and Mills [21], and [3ZP]orthophosphate-labelled 
proteins by autoradiography, using XAR films (Eastman Kodak 
Company, Rochester, NY) at -7O’C. 
2.5. In vitro kinase assays 
Lysates of unlabelled cells prepared as above described for 
3SSmethionine-labelled c lls, were adjusted to the same concentration 
of proteins on the basis of measures of the protein content by the 
method of Bradford [22], and immune precipitations were performed 
as described above. Immune complexes were collected, and kinase 
assays performed by previously described procedures [14,23]. 
2.6. Tryptic peptide mapping 
Tryptic peptides were prepared and analyzed by electrophoresis n 
1% ammonium carbonate, pH 8.9, and chromatography as described 
by Courtneidge 1191. 
2.7. Western blotting 
Lysates (4&50 ,ug proteins/well) were subjected to SDS-PAGE on 
316 
10% gels and transferred to nitrocellulose membranes (Bio-Rad, 
Richmond, CA) using a Bio-Rad Trans Blot Apparatus. Blots were 
rinsed in PBS and incubated for 2 h in blocking buffer (3% BSA, 
0.025% Tween 20 in PBS). After overnight incubation at 4°C with 2.5 
pg/ml affinity puritied antibodies diluted in blocking buffer, blots were 
washed 2 times for 30 min with PBS, and incubated with 5 &ml rabbit 
anti-mouse IgG diluted in blocking buffer. After 2 h of incubation the 
blots were washed as above, and probed with donkey anti-rabbit 
horseradish peroxidase-conjugated antibodies (Amersham) diluted 
1: 15,000 in blocking buffer. Bound antibodies were revealed with the 
Enhanced Chemiluminescence Western blotting detection reagent 
(ECL, Amersham) using Trimax 3 M X-ray films. 
3. RESULTS 
3.1. Synthesis of ~60”’ in human monocytes and mon- 
ocyte-derived macrophages 
In vitro kinase assays on anti-p60”” immune precipi- 
tates allowed us to detect a higher ~60”” kinase activity 
in monocytes compared to macrophages derived from 
cultivation of monocytes for 7-9 days [14]. To under- 
stand whether this reflects a difference in ~60”” expres- 
sion, we analysed de novo ~60” synthesis by labelling 
cells with [35S]methionine. As shown in Fig. 1, the anti- 
~60”” MAb 327 precipitated higher amounts of labelled 
A B C A B C 
Fig. 1. ~60’~ synthesis in monocytes and monocyte-derived macro- 
phages. (Upper panel) Cell monolayers were labelled with 
[35S]methionine, and lysates prepared as described in section 2. Lysates 
were immune precipitated with the anti-transfertin receptor antibody, 
5E9 (lanes l-3 from the left), or the antip60”” antibody 327 (lanes 4-6 
from the left). Lanes A, monocytes cultivated for 2 days; lanes B, 
macrophages derived from cultivation of monocytes for 7 days; lanes 
C, macrophages derived from cultivation of monocytes for 7 days in 
the presence of 100 U/ml IFN-I. The last lane at the right shows 
migration of markers of the molecular weights (in kDa) indicated at 
the right side of the panel. One representative of three experiments i  
reported. (Lower panel) In vitro kinase assays on anti-transferrin 
receptor (lanes 1,2), or anti-p60sn’ immune precipitates (lanes 3-5). 
Lanes 1,4, monocyte-derived macrophages; lanes 2,5, monocyte-de- 
rived macrophages cultivated in the presence of 100 U/ml IFN-I; 
lane 3, monocytes. 
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~60”” from lysates of monocytes (lanes A) compared to 
monocyte-derived macrophages (lanes B). The de- 
creased synthesis of ~60”” in monocyte-derived macro- 
phages has the feature of a relatively selective phenom- 
enon, as exemplified by the results reported in Fig. 1 
which show that, as expected from previous observa- 
tions [24], de novo synthesis of the transferrin receptor 
was actually higher in monocyte-derived macrophages 
(compare lanes A, and B). 
We did not find any substantial alteration of immune 
precipitable [3’S]methionine-labelled ~60”” in mon- 
ocyte-derived macrophages cultivated in the presence of 
IFN-y (Fig. 1, lanes C). However, in agreement with 
studies with murine macrophages [25,26], we obtained 
evidence that this cytokine caused a decrease in the 
synthesis of transferrin receptor (compare lanes B and 
C). That IFN-y-treated monocyte-derived macro- 
phages did not synthesise higher amounts of ~60”” is in 
apparent contrast with our previous studies [14], and 
the experiments the results of which are reported in Fig. 
1. In fact, we detected a higher kinase activity in anti- 
~60”” immune precipitates from lysates of IFN-*/- 
treated monocyte-derived macrophages. We therefore 
concluded that analysis of ~60”” synthesis in 
[35S]methionine-labelled c lls could have not allowed us 
to detect differences in ~60”” expression in cytokine- 
treated compared to control monocyte-derived macro- 
phages. We then analysed ~60”” expression by Western 
blotting (Fig. 2). 
3.2. Analysis of ~60”’ expression in monocyte-derived 
macrophages 
This type of analysis showed that after treatment for 
7 days with IFN-y, as well as with TNF-a, monocyte- 
derived macrophages expressed higher amounts of 
~60”“. That we detected higher ~60”” synthesis in mon- 
ocytes but not in IFN-y-treated monocyte-derived mac- 
rophages (see Fig. 1) may be explained by the fact that 
we analysed ~60”” synthesis after several days of cyto- 
kine treatment. We did not attempt to trace ~60”” syn- 
thesis at different days of cytokine treatment. However, 
the data obtained by Western blot analysis show that 
a correlation exists between ~60” kinase activity in 
anti- ~60”” immune precipitates and p60”” expression 
(Fig. 2). 
3.3. In vivo phosphorylation of ~60”’ in monocyte-de- 
rived macrophages 
~60”” activity has been shown to be regulated by 
phosphorylation of critical tyrosine residues [l 11. To 
clarify whether enhanced p6Osrc activity in cytokines- 
treated monocyte-derived macrophages might also be 
due to alterations in p6Osrc phosphorylation, we analy- 
sed tryptic digests of in vivo phosphorylated p6Osrc 
(Fig. 3). This type of analysis allowed us to identify five 
major phosphopeptides (lettered a-e in Fig. 3) which 
did not show any major qualitative or quantitative al- 
terations in IFN-y-treated, as well as TNF-a-treated, 
monocyte-derived macrophages. We did not attempt to 
+-INK3 _ - - +lw-a +mwu +TNF-a 
L%P~ 10 20 40 10 20 40 
Fig. 2. p6pX expression in monocyte-derived macrophages. Monocyte-derived macrophages were cultivated for 7 days in the absence (-), or the 
presence (+) of 100 U/ml IFN-y, or 5 ng/ml TNF-a. p60” expression was analysed by in vitro kinase assays (panels A), or by Western blotting 
(panels B). Panel B2.b shows a representative pattern of expression of the cytosolic NADPH oxidase component p47rh”, a phagocyte-specific 
protein the expression of which is enhanced by IFN-y (see [39]). The results of independent experiments numbered l-3 are reported. 
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Fig. 3. Tryptic phosphopeptides of ~60’~ from [32P]orthophosphate- 
labelled monocyte-derived macrophages cultivated in the presence, or 
the absence of cytokines. Monocyte-derived macrophages, cultivated 
for 7 days in the absence, or the presence of 100 U/ml IFN-y and 
5 @ml TNF-a were labelled with “P orthophosphate as described in 
section 2. Immune precipitated p60”” was subjected to SDS-PAGE, 
identified by autoradiography and excised from the gel. Samples were 
digested with trypsin, and phosphopeptides were resolved by electro- 
phoresis at pH 8.9 in the horizontal dimension (anode at left) and 
chromatography in the vertical dimension. The cross marks the origin. 
(A) Control monocyte-derived macrophages. (B) Monocyte-derived 
macrophages cultivated in the presence of IFN-I. (C) Monocyte- 
derived macrophages cultivated in the presence of TNF-a. (D) Tryptic 
phosphopeptides of p6Vrc immune precipitated from monocyte-de- 
rived macrophages and labelled in vitro with [Y-~‘P]ATP. 
identify the phosphopeptides obtained by tryptic diges- 
tion. However, when p60”” was phosphorylated in 
vitro, and then digested with trypsin, only one major 
phosphorylated fragment was observed (Fig. 3D), 
which migrated to the same position of fragment d. As 
the major site of in vitro phosphorylation of p60”” is the 
tyrosine at position 416 (see [l 11) fragment d in macro- 
phages labelled in vivo with [32P]orthophosphate is 
likely to be Tyr-416. Also other types of analysis of in 
vivo phosphorylated p60”” (V8 protease digestion, cy- 
anogen bromide clereage) did not reveal any alteration 
of ~60”” phosphorylation in cytokine-treated macro- 
phages (not shown). 
U937 CELLS 
PMA 
72 bra. 48hn. 
IFNq 1FN-y + 
TNFa 
46 ’ . . 
U937 CELLS 
anti-p60ace anti-pCWfYn 
IF&y - + + - + + 
TNFa - - + - - + 
HL-60 CELLS 
anti-p60rrc anti-pS9fyn 
IFN-7 - + - + - + - + 
TNFu - - + + - - + + 
Fig. 4. ~60”” expression in myelomonocytic cell lines induced to differ- 
entiate with cytokines. U937 and HL-60 cells were cultivated for 5 
days in the presence of 100 U/ml IFN-y alone, or in combination with 
1 &ml TNF-cc. ~60”” or p59ry”, were immune precipitated from ly- 
sates of cytokine-treated, or undifferentiated cells and in vitro kinase 
assays performed as described in section 2. In the upper panel, the 
effect of treatment with 100 @ml phorbol myristate acetate (PMA) 
for the time indicated is shown for comparison. 
3.4. ~60”” expression in myelomonocytic cell lines differ- 
entiated with cytokines 
Early studies showed that induction of human myelo- 
monocytic cell line differentiation by phorbol esters or 
dimethyl sulfoxide is accompanied by enhanced expres- 
sion of p60”” [27,28]. IFN-y and TNF-a synergistically 
induce immature myelomonocytic ell lines to differen- 
tiate into cells with phenotypic, functional, and prolifer- 
ative characteristics of cells of the monocytic lineage 
[15,16]. We therefore sought to investigate whether cy- 
tokine-induced differentiation is also accompanied by 
enhanced ~60”” expression. The results reported in Fig. 
4 show that this is the case. In fact, IFN-7, alone, or in 
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combination with TNF-ol, enhanced the detectability of 
~60”” in in vitro kinase assays in both U937 and HL-60 
cells. A comparison with cells induced to differentiate 
by phorbol myristate acetate (PMA), showed that treat- 
ment of U937 cells with IFN-y and TNF-01 induced 
~60”” kinase activity even more effectively than PMA 
(Fig. 4, upper panel). Induction of ~60”” activity by 
cytokines does not appear to reflect a non selective in- 
duction of different members of the src family of tyro- 
sine kinases. In fact, neither undifferentiated, nor cyto- 
kine-differentiated, U937, and HL-60 cells expressed 
detectable levels of ~59~Y” (Fig. 4). ~62~~~ activity was 
also at the limit of detection, and independently of the 
state of differentiation, in these two cell lines (not 
shown). Experiments with [35S]methionine-labelled c lls 
showed that induction of ~60”” activity was accompa- 
nied by enhanced ~60”” synthesis; this was undetectable 
in undifferentiated U937, or HL-60 cells, but increased 
after induction of differentiation with cytokines (not 
shown). 
4. DISCUSSION 
The data presented in this paper demonstrate that 
~60”” expression is higher in human monocytes than in 
macrophages derived from in vitro cultivation of mon- 
ocytes, and IFN-y and TNF-a increase expression of 
~60”” in monocyte-derived macrophages. This pattern 
of ~60”” expression correlates with a functional state 
which is typical of mononuclear phagocytes fully com- 
mitted to play a role as effector cells in host defences. 
In fact, macrophages differentiated in vitro [7-91 or 
isolated from lung [4-61 have a decreased capability of 
producing molecules toxic for pathogens compared to 
circulating monocytes, but IFN-y and TNF-a activate 
their microbicidal and cytotoxic functions [29,30]. That 
a correlation exists between ~60”” expression and the 
acquirement of phenotypic properties of mature mon- 
ocytes is also reinforced by the finding that immature 
monocytic cell lines differentiated with IFN-y and 
TNF-a display a higher ~60”” activity. 
Gee et al. [28] showed that, among leukocytes, mon- 
ocytes express p60”‘” at the highest level, and the state 
of differentiation of human myeloid leukemic cells cor- 
relates with ~60”” expression. Differentiation into mon- 
ocytic cells of U937 and HL60 cells induced with phor- 
bol esters is accompanied by enhanced expression of src 
[27,28]. Our findings are the first to establish that ex- 
pression of ~60”” can be modulated in mature mononu- 
clear phagocytes. 
Extensive evidence has accumulated indicating that 
members of the src family of tyrosine kinases, including 
the product of the SIC gene, are not merely implicated 
in regulation of cell growth, or differentiation [11,12]. 
For example, high levels of ~60”” kinase activity are 
detectable in post-mitotic neurons [31], and platelets 
[32]. So far, the role of this family of tyrosine kinases 
in regulation of phagocyte functions has probably been 
underestimated. Both neutrophils and mononuclear 
phagocytes express different members of the SIC family 
of tyrosine kinases [12,13]. Evidence has started to accu- 
mulate indicating that expression of these molecules is 
also regulated in a complex manner upon activation of 
mononuclear phagocytes by bacterial-derived products 
or cytokines. For example, bacterial endotoxin en- 
hances expression of both hck mRNA and protein in 
human monocyte-derived macrophages, and IFN-y 
acts in synergy with endotoxin [33]. In murine bone 
marrow-derived monocytic cells, M-CSF, as well as 
GM-CSF, endotoxin and IFN-y induce fgr expression 
1341. 
The possible role of p60”‘” and other intracellular ty- 
rosine kinases in regulation of mononuclear phagocyte 
functions is unknown. Interestingly, the targeted dis- 
ruption of src leads to an impairment of osteoclast func- 
tions in mice [35]. Stimulation of a macrophage cell line 
with endotoxin [36] or myelomonocytic cell lines with 
ligands for Fey receptors [37,38] triggers protein tyro- 
sine phosphorylation. However, the kinases involved in 
this event have not been identified. These observations 
point towards an important role of tyrosine kinases in 
the regulation of phagocyte functions. The evidence 
presented in this paper that expression of the product 
of the protooncogene, c-src, is modulated by macro- 
phage activating cytokines suggest that this tyrosine 
kinase belongs to the set of proteins involved in func- 
tions of the activated macrophage. 
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